Clinical Trials Browser

Phase 3 × Completed × Disease × Clear all

NCT04186845 2025-09-22

Spotlight

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

NCT04410133 2025-08-28

REVELATE

Phase 3 Completed

151 enrolled 29 charts

Brain Neoplasms, Disease

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Disease, Prostatic Neoplasms

NCT01093196 2024-11-07

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma

NCT02215980 2024-07-22

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Phase 3 Completed

Disease, Multiple Myeloma

NCT03739684 2021-06-14

CONDOR

Phase 3 Completed

208 enrolled 10 charts

Disease, Prostatic Neoplasms

NCT00171873 2020-03-26

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Phase 3 Completed

85 enrolled 6 charts

Disease, Neoplasms, Neuroendocrine Tumors

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

Disease, Neuroblastoma, Pheochromocytoma

NCT02615067 2019-04-10

proSPECT-AS

Phase 3 Completed

Disease, Prostatic Neoplasms

NCT03645018 2018-09-14

SOS2

Phase 3 Completed

Disease, Lung Neoplasms, Neoplasms

NCT00232934 2018-08-02

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma, Neoplasms, Plasma Cell

NCT01476774 2015-07-08

NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

Phase 3 Completed

Disease

NCT00136890 2013-01-15

ELPET

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Neoplasms

NCT00147472 2012-06-22

Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)

Phase 3 Completed

Disease, Head and Neck Neoplasms, Neoplasms

NCT00136864 2011-11-18

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Neoplasms

NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00201942 2007-10-18

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Phase 3 Completed

Breast Neoplasms, Disease